Sun Pharmaceutical Industries Ltd (SUN.BO) Key Developments | Reuters.com
Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

764.00INR
1 Jul 2016
Change (% chg)

Rs0.40 (+0.05%)
Prev Close
Rs763.60
Open
Rs762.00
Day's High
Rs762.00
Day's Low
Rs762.00
Volume
409,738
Avg. Vol
641,530
52-wk High
Rs965.15
52-wk Low
Rs706.40

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries Ltd and Merck & Co. Inc. enter into licensing agreement for Tildrakizumab
Wednesday, 17 Sep 2014 08:30am EDT 

Sun Pharmaceutical Industries Ltd and Merck & Co. Inc:Says through their respective subsidiaries, announced an exclusive worldwide licensing agreement for Merck's investigational therapeutic antibody candidate, tildrakizumab.Under terms, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of US$80 mln.Merck will continue all clinical development and regulatory activities, which will be funded by Sun Pharma.Transaction is subject to customary closing conditions, including the requirements under the Hart Scott-Rodino Antitrust Improvements Act.  Full Article

Sun Pharmaceutical Industries Ltd's Caraco Pharmaceutical initiates recall of cephalexin capsules-Business Standard
Monday, 18 Aug 2014 03:25am EDT 

Sun Pharmaceutical Industries Ltd:Caraco Pharmaceutical Laboratories, the US-based unit of Sun Pharmaceuticals, has initiated a recall of multiple lots of cephalexin capsules from the US market, according to a PTI report-Business Standard.Citing a notification by the USFDA, the report says that the recall of the 340,553 units of 500 mg and 113,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under 'Class-II' classification.  Full Article

Sun Pharmaceutical Industries Ltd recommends payment of dividend
Tuesday, 12 Aug 2014 10:58pm EDT 

Sun Pharmaceutical Industries Ltd:Says board of Directors of the company have recommended payment of dividend of 1.50 indian rupees for the year ended Mar.31, 2014.  Full Article

Sun Pharmaceutical Industries Ltd Appoints Chief Financial Officer
Tuesday, 12 Aug 2014 10:45pm EDT 

Sun Pharmaceutical Industries Ltd:Appoints Uday Baldota as Chief Financial Officer (CFO) of Company with immediate effect.  Full Article

Sun Pharmaceutical Industries Ltd's subsidiary acquires Pharmalucence Inc
Tuesday, 15 Jul 2014 11:34pm EDT 

Sun Pharmaceutical Industries Ltd:Announces acquisition of Pharmalucence Inc, by one of its subsidiaries.Pharmalucence has sterile injectable capacity in the US, supported by R&D capabilities.Terms of the acquisition were not disclosed.  Full Article

India's Sun Pharma enters dermatology segment to expand retail offering

MUMBAI, June 8 India's Sun Pharmaceutical Industries Ltd said on Wednesday it had entered the dermatology segment as part of an initiative to further expand its retail offerings.